Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics, Inc. is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis and non-cannabis products, with an emphasis on life science-based innovation and production excellence. Emerald’s three distinct operating assets are designed to uniquely serve the Canadian marketplace and international opportunities.

Recent News

  • Emerald Health Therapeutics Announces Full Prepayment of Convertible Debentures

    Vancouver, British Columbia--(Newsfile Corp. - November 24, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has fully prepaid in cash all amounts owing under the convertible debentures issued to certain Canadian institutional accredited investors (the "Debentureholders") by the Company on September 9, 2019 (the "Convertible Debentures"). As a result, the Convertible Debentures are now terminated and the Company has no further obligations thereunder.The Convertible Debentures accrued interest at a rate of 5% per annum and were...

    2020-11-24 7:00 AM EST
  • RETRANSMISSION: Emerald Health Therapeutics Completes Sale of Pure Sunfarms Interest and Achieves Pivotal Milestone in Transforming its Business

    Vancouver, British Columbia--(Newsfile Corp. - November 2, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has completed the previously disclosed sale of its 41.3% interest in Pure Sunfarms Corp. ("PSF") to Village Farms International, Inc. ("Village Farms") (NASDAQ: VFF) (TSX: VFF) for consideration of $79,900,000.As previously announced by the Company, on September 8, 2020, it entered into a share purchase agreement (the "Share Purchase Agreement") with Village Farms in respect of the sale of the Company's...

    2020-11-02 9:11 AM EST
  • Emerald Health Therapeutics Completes Sale of Pure Sunfarms Interest & Achieves Pivotal Milestone in Transforming its Business

    Vancouver, British Columbia--(Newsfile Corp. - November 2, 2020) -   Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has completed the previously disclosed sale of its 41.3% interest in Pure Sunfarms Corp. ("PSF") to Village Farms International, Inc. ("Village Farms") (NASDAQ: VFF; TSX: VFF) for consideration of $79,900,000.As previously announced by the Company, on September 8, 2020, it entered into a share purchase agreement (the "Share Purchase Agreement") with Village Farms in respect of the sale of the...

    2020-11-02 8:33 AM EST
  • Emerald Shareholders Vote in Favour of Sale of Pure Sunfarms

    Vancouver, British Columbia--(Newsfile Corp. - October 29, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") is pleased to announce that its shareholders have voted today at its annual general and special meeting (the "Meeting") to approve the sale of the Company's 41.3% interest in Pure Sunfarms Corp. ("PSF") to Village Farms International, Inc. ("Village Farms"). As previously announced by the Company, on September 8, 2020, it entered into a share purchase agreement (the "Share Purchase...

    2020-10-29 2:10 PM EDT
  • Emerald Health Therapeutics Launches Flavoured Cannabis Oils, Expanding SYNC(TM) Product Line

    Combination of appealing natural flavourings and terpenes offers unique consumer experienceEmerald also launches new SYNC CBD nanoemulsion-based Fast Action Spray in BC and SaskatchewanVancouver, British Columbia--(Newsfile Corp. - October 19, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has expanded its SYNCTM product line with the launch of new uniquely flavoured CBD cannabis oil products. Emerald has made its first product shipments to British Columbia, Saskatchewan and Nova Scotia, with availability for purchase by consumers expected this week....

    2020-10-19 7:00 AM EDT
  • Emerald Health Therapeutics Receives Standard Processing License for Richmond, BC Greenhouse Facility

    Vancouver, British Columbia--(Newsfile Corp. - October 13, 2020) -  Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has received a newly issued Standard Processing License (the "Processing License") from Health Canada for its 78,000 square foot organic-certified greenhouse facility in Richmond, BC.The Processing License expands on the site's existing cultivation licence to grow and produce bulk dried cannabis to now also permit the processing of consumer-ready dried product formats in its purpose-built cannabis production facility. It also provides the...

    2020-10-13 7:00 AM EDT
  • Emerald Health Therapeutics Closes Shares for Debt Transaction

    Vancouver, British Columbia--(Newsfile Corp. - September 16, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has closed its previously announced shares for debt financing. Further to its news release dated August 21, 2020, the Company has settled $625,000 of debt (the "Debt") payable to the holders (the "Holders") of convertible debentures of the Company issued on September 10, 2019 (the "Convertible Debentures"). The Debt represents accrued interest on the Convertible Debentures to June 30, 2020....

    2020-09-16 7:47 PM EDT
  • Emerald Health Therapeutics and STENOCARE Receive Swedish Medicines Agency Approval to Provide Medical Cannabis Oil to Patients

    Vancouver, British Columbia--(Newsfile Corp. - September 10, 2020) -  Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") and STENOCARE A/S today announced that they have received special approval from the Swedish Medicines Agency to provide medical cannabis oil to Swedish patients who have applied via their doctor to use such products for treatment purposes.STENOCARE, located in Denmark, is a leading supplier of prescription-based medical cannabis products for patient treatment to help them improve quality of life. Under an agreement...

    2020-09-10 7:00 AM EDT